Skip to main content
Company record · Manage
Belgian companySituation normaleSociété anonyme

EUMEDICA

Enterprise number
0403.057.665
VAT number
BE0403057665
Registered office
Chemin de la Nauwelette 1, 7170 Manage
Incorporated on
1 January 1951
Members only
Health score
Latest financial year
2025
m02-f model
Size
Medium
155,6 FTE
Equity
€26.3M
Financial year 2025
Net result
€7.2M
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

EUMEDICA is a Belgian company (Société anonyme) whose registered office is established at 7170 Manage. Its main activity falls under “Commerce de gros de produits pharmaceutiques et médicaux” (NACE 46460).

Legal form
Société anonyme
Legal situation
Situation normale
Date of incorporation
1 January 1951
Main activity (NACE)
46460Commerce de gros de produits pharmaceutiques et médicaux

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Your risk analysis on this company

AML Company ran EUMEDICA through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

2 active establishment units declared with the CBE.

2
Implantation
Manage

2 establishments · 1 municipality

Registered office2 establishments
Registered office
Chemin de la Nauwelette 1
7170 Manage
Map
Establishment2017.791.228
Chemin de la Nauwelette 1
7170 Manage
Map
Establishment 22327.690.093
rue des Brasseries 4
7170 Manage
Map

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€26,313,351€7,169,631
2024€21,971,832€5,827,742
2023––
2022€14,179,049€526,895

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
43%
0,9%
Financial year 2025

Equity / balance sheet total

Liquidity
1,48 x
0,02
Financial year 2025

Current assets / debts due within one year

Net margin
8,8%
1,5%
Financial year 2025

Result for the year / turnover

Operating margin
12,3%
2,5%
Financial year 2025

Operating result / turnover

Long-term debt
11,3%
3,7%
Financial year 2025

Debts due after one year / balance sheet total

Return on equity
27,2%
0,7%
Financial year 2025

Result for the year / equity

Over the most recent filed years

Balance sheet structure

SolvencyLong-term debt
Year-on-year comparison
Ratio202520242023Trend
Solvency
43%
0,9%
42,1%
-
Liquidity
1,48 x
0,02
1,46 x
-
Net margin
8,8%
1,5%
7,4%
-
Operating margin
12,3%
2,5%
9,8%
-
Long-term debt
11,3%
3,7%
15,1%
-
Return on equity
27,2%
0,7%
26,5%
-

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (50)▾
Financial yearFilingFiling typeModelSource
01/01/2025 → 31/12/202515/07/2026Initialm02-fBNB
01/01/2024 → 31/12/202416/07/2025Initialm02-fBNB
01/01/2023 → 31/12/202323/08/2024Initialm02-fBNB
01/01/2022 → 31/12/202209/08/2023Initialm02-fBNB
01/01/2021 → 31/12/202124/11/2022Correctionm02-fBNB
01/01/2021 → 31/12/202114/09/2022Initialm02-fBNB
01/01/2020 → 31/12/202030/08/2021Initialm02-fBNB
01/01/2019 → 31/12/201903/09/2020Initialm02-fBNB
01/01/2018 → 31/12/201808/08/2019Initialm02-fBNB
01/01/2017 → 31/12/201714/08/2018Initialm02-fBNB
01/01/2016 → 31/12/201603/08/2017Initialm02-fBNB
01/01/2015 → 31/12/201530/08/2016Initialm02-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

What the EUMEDICA record does not say

Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.

Is EUMEDICA subject to anti-money-laundering obligations in Belgium?
In principle no. The activity declared in the register for EUMEDICA is not among the professions expressly covered by the act of 18 September 2017. This general information is not legal advice.
Did EUMEDICA file its annual accounts on time?
Yes. EUMEDICA filed its latest annual accounts with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 15 July 2026, ahead of 31 July 2026. Article 3:10 of the Code of Companies and Associations requires filing within thirty days of approval and at the latest seven months after the financial year closes.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
76 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 15 July 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m02-fFiled accounts2026-00295940
    2. 12 March 2026Appointments · ResignationsView the notice26036119
  2. 2025
    1. 3 November 2025Registered officeView the notice25367124
    2. 16 July 2025Annual accounts filed·Financial year ended 31 December 2024 · Model m02-fFiled accounts2025-00280812
    3. 21 March 2025Appointments · ResignationsView the notice25037946
    4. 17 January 2025Appointments · ResignationsView the notice25007867
  3. 2024
    1. 23 August 2024Annual accounts filed·Financial year ended 31 December 2023 · Model m02-fFiled accounts2024-00372129
  4. 2023
    1. 7 September 2023Appointments · ResignationsView the notice23114821
    2. 9 August 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m02-fFiled accounts2023-00321210
    3. 3 February 2023Appointments · ResignationsView the notice23016934
  5. 2022
    1. 24 November 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m02-fFiled accounts2022-20525564
    2. 14 September 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m02-fFiled accounts2022-20429752

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, audience-measurement cookies (hosted in the EU) to improve our services. Learn more.